The Cancer Letter

Inside information on cancer research and drug development

Vol.
31
No.
21
May 27, 2005May 27, 2005
Free
DOWNLOAD THE PDF

Combined analysis moves Herceptin to adjuvant setting in breast cancer.

Breast cancer session was ASCO equivalent of a rock concert, discussant says.

Avastin doubles progression-free survival in metastatic disease.

Also MQSA should require mammography facilities to gather data on interpretation, cancer policy board committee says.

Colorado universities install huge NMR magnet. NCI to transfer 5 A Day to CDC.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account